Mark S. Levine Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark S. Levine.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark S. Levine. Mark S. Levine is General Counsel in Flexion Therapeutics Inc ($FLXN) and SVP & General Counsel in Flexion Therapeutics Inc ($FLXN) and SVP,General Counsel & Sec. in Minerva Neurosciences, Inc. ($NERV) and VP,General Counsel & Sec. in Minerva Neurosciences, Inc. ($NERV).
Latest Insider Trading Transactions of Mark S. Levine
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 07 2021 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Sell | S | 11.13 | 6,829 | 76,007 | 107,431 | 114.3 K to 107.4 K (-5.98 %) |
| Jul 20 2020 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Grant | A | 0.00 | 38,750 | 0 | 114,260 | 75.5 K to 114.3 K (+51.32 %) |
| Jul 20 2020 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Grant | A | 0.00 | 38,750 | 0 | 114,260 | 75.5 K to 114.3 K (+51.32 %) |
| Jun 24 2020 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Grant | A | 10.83 | 1,023 | 11,079 | 75,510 | 74.5 K to 75.5 K (+1.37 %) |
| Jan 07 2020 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Sell | S | 0.00 | 3,724 | 0 | 43,487 | 47.2 K to 43.5 K (-7.89 %) |
| Jun 24 2019 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Grant | A | 9.81 | 1,213 | 11,900 | 46,273 | 45.1 K to 46.3 K (+2.69 %) |
| Mar 05 2019 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Option Exercise | A | 14.75 | 18,000 | 265,500 | 18,000 | |
| Mar 05 2019 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Grant | A | 0.00 | 36,000 | 0 | 45,060 | 9.1 K to 45.1 K (+397.35 %) |
| Jan 04 2019 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Sell | S | 12.36 | 734 | 9,072 | 9,060 | 9.8 K to 9.1 K (-7.49 %) |
| Jun 22 2018 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Buy | J | 21.22 | 539 | 11,438 | 8,872 | 8.3 K to 8.9 K (+6.47 %) |
| Feb 02 2018 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Option Exercise | A | 22.31 | 33,333 | 743,659 | 33,333 | |
| Feb 02 2018 | FLXN | Flexion Therapeuti ... | Levine Mark S. | General Counsel | Grant | A | 0.00 | 8,333 | 0 | 8,333 | 0 to 8.3 K |
| Jun 26 2017 | FLXN | Flexion Therapeuti ... | Levine Mark S. | SVP & General Couns ... | Option Exercise | A | 21.74 | 125,000 | 2,717,500 | 125,000 | |
| Jun 05 2017 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Option Exercise | M | 5.19 | 17,500 | 90,825 | 39,774 | |
| Jun 05 2017 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Sell | S | 11.00 | 17,500 | 192,500 | 0 | 17.5 K to 0 (-100.00 %) |
| Jun 05 2017 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Buy | M | 5.19 | 17,500 | 90,825 | 17,500 | 0 to 17.5 K |
| Jan 06 2017 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Option Exercise | M | 5.19 | 250 | 1,298 | 57,274 | |
| Jan 06 2017 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Option Exercise | M | 4.71 | 17,250 | 81,248 | 51,750 | |
| Jan 06 2017 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Sell | S | 12.00 | 17,500 | 210,000 | 0 | 17.5 K to 0 (-100.00 %) |
| Jan 06 2017 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Buy | M | 5.19 | 250 | 1,298 | 17,500 | 17.3 K to 17.5 K (+1.45 %) |
| Jan 06 2017 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Buy | M | 4.71 | 17,250 | 81,248 | 17,250 | 0 to 17.3 K |
| Dec 16 2016 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Option Exercise | A | 13.45 | 35,000 | 470,750 | 35,000 | |
| Dec 16 2016 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Dec 08 2015 | NERV | Minerva Neuroscien ... | Levine Mark S. | SVP,General Counsel ... | Option Exercise | A | 4.71 | 69,000 | 324,990 | 69,000 | |
| Apr 16 2015 | NERV | Minerva Neuroscien ... | Levine Mark S. | VP,General Counsel ... | Option Exercise | A | 5.19 | 57,524 | 298,550 | 57,524 |
Page: 1